Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 5, 2010, Pages 917-923

  van der Plas, Mariena J A ^a   Dambrot, Cheryl ^a   Dogterom Ballering, Heleen C M ^a   Kruithof, Simone ^a   van Dissel, Jaap T ^a   Nibbering, Peter H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bacterial killing; Clindamycin; Daptomycin; Lucilia sericata; Vancomycin

Indexed keywords

CLINDAMYCIN; DAPTOMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT;

ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BIOFILM; DRUG EFFICACY; IN VITRO STUDY; MAGGOT; MICROTITER PLATE ASSAY; NONHUMAN; STAPHYLOCOCCUS AUREUS; ANIMAL; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; FLY; HUMAN; ISOLATION AND PURIFICATION; LARVA; MICROBIAL VIABILITY; PHYSIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; BIOLOGICAL PRODUCTS; CLINDAMYCIN; DAPTOMYCIN; DIPTERA; DRUG SYNERGISM; HUMANS; LARVA; MICROBIAL VIABILITY; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 77953702881     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq042     Document Type: Article

References (36)

1. Bartus CL, Margolis DJ. Reducing the incidence of foot ulceration and amputation in diabetes. Curr Diab Rep 2004; 4: 413-8.
2. Ferrell BA, Josephson K, Norvid P et al. Pressure ulcers among patients admitted to home care. J Am Geriatr Soc 2000; 48: 1042-7.
3. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G et al. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-24.
4. Peters EJ, Childs MR, Wunderlich RP et al. Functional status of persons with diabetes-related lower-extremity amputations. Diabetes Care 2001; 24: 1799-804.
5. Gjodsbol K, Christensen JJ, Karlsmark T et al. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006; 3: 225-31.
6. Harrison-Balestra C, Cazzaniga AL, Davis SC et al. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg 2003; 29: 631-5.
7. Davis SC, Martinez L, Kirsner R. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep 2006; 6: 439-45.
8. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis 2004; 17: 91-6.
9. Stoodley P, Sauer K, Davies DG et al. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002; 56: 187-209.
10. Sheldon AT Jr. Antibiotic resistance: a survival strategy. Clin Lab Sci 2005; 18: 170-80.
11. Gilbert P, Allison DG, McBain AJ. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? Symp Ser Soc Appl Microbiol 2002; 98S-110S.
12. Leid JG, Shirtliff ME, Costerton JW et al. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun 2002; 70: 6339-45.
13. Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 2005; 28: 461-71.
14. Wagner C, Kaksa A, Muller W et al. Polymorphonuclear neutrophils in posttraumatic osteomyelitis: cells recovered from the inflamed site lack chemotactic activity but generate superoxides. Shock 2004; 22: 108-15.
15. Mumcuoglu KY, Ingber A, Gilead L et al. Maggot therapy for the treatment of diabetic foot ulcers. Diabetes Care 1998; 21: 2030-1.
16. Sherman RA, Wyle FA, Vulpe M et al. The utility of maggot therapy for treating chronic wounds. Am J Trop Med Hyg 1993; Suppl: 266.
17. Stoddard SR, Sherman RA, Mason BE et al. Maggot debridement therapy. An alternative treatment for nonhealing ulcers. J Am Podiatr Med Assoc 1995; 85: 218-21.
18. van der Plas MJA, Jukema GN, Wai SW et al. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 2008; 61: 117-22.
19. van der Plas MJA, van der Does AM, Baldry M et al. Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes Infect 2007; 9: 507-14.
20. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA 2005.
21. Nibbering PH, Ravensbergen E, Welling MM et al. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect Immun 2001; 69: 1469-76.
22. van Ogtrop ML, Mattie H, Guiot HFL et al. Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo. Antimicrob Agents Chemother 1990; 34: 1932-7.
23. Flemming K, Klingenberg C, Cavanagh JP et al. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. J Antimicrob Chemother 2009; 63: 136-45.
24. Smith K, Perez A, Ramage G et al. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents 2009; 33: 374-8.
25. Desrosiers M, Bendouah Z, Barbeau J. Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro. Am J Rhinol 2007; 21: 149-53.
26. Tote K, Berghe DV, Deschacht M et al. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Int J Antimicrob Agents 2009; 33: 525-31.
27. Howell-Jones RS, Wilson MJ, Hill KE et al. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005; 55: 143-9.
28. Robinson W, Norwood VH. The role of surgical maggots in the disinfection of osteomyelitis and other infected wounds. J Bone Joint Surg Am 1933; 15: 409-12.
29. Mumcuoglu KY, Miller J, Mumcuoglu M et al. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J Med Entomol 2001; 38: 161-6.
30. Sherman RA, Wyle FA, Thrupp L. Effects of seven antibiotics on the growth and development of Phaenicia sericata (Diptera: Calliphoridae) larvae. J Med Entomol 1995; 32: 646-9.
31. Alder J. The use of daptomycin for Staphylococcus aureus infections in critical care medicine. Crit Care Clin 2008; 24: 349-63.
32. English BK, Maryniw EM, Talati AJ et al. Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin. Antimicrob Agents Chemother 2006; 50: 2225-7.
33. Wale LJ, Shelton AP, Greenwood D. Scanning electronmicroscopy of Staphylococcus aureus and Enterococcus faecalis exposed to daptomycin. J Med Microbiol 1989; 30: 45-9.
34. Rosner K, Ross C, Karlsmark T et al. Immunohistochemical characterization of the cutaneous cellular infiltrate in different areas of chronic leg ulcers. APMIS 1995; 103: 293-9.
35. Loots MA, Lamme EN, Zeegelaar J et al. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998; 111: 850-7.
36. Wetzler C, Kampfer H, Stallmeyer B et al. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000; 115: 245-53.